Sutro Biopharma Announces Pricing of $75 Million Underwritten OfferingGlobe Newswire • about 1 month agoSOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...